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Editorial Comment
SPECT Thallium Imaging in the
Diagnosis of Myocardial Ischemia*
ABDULMASSIH S. ISKANDRIAN, MD, FACC
Philadelphia, Pennsylvania
Diamond (I) and Gould (2) raise independently interesting
points concerning our recent study (3). Their thoughtful
comments addressed Bayes' theorem, selection bias, speci-
ficity, normalcy and observed versus corrected test results,
and we concur with the analysis and major conclusions by
Diamond. Regrettably however, their comments did not
address the major conclusion of our study: the effect of level
of exercise on results of single photon emission computed
tomography (SPECT) with thallium-20I. Our results clearly
demonstrated improved sensitivity in patients with adequate
exercise end points compared with those with submaximal
exercise performance, These results. which were derived
from a large cohort of patients, have important clinical
implications, given the availability of alternative techniques
of stress testing such as thallium imaging during dipyrida-
mole- or adenosine-induced coronary hyperemia.
The group of patients with a low pretest likelihood of
coronary artery disease and a normalcy rate of 93% were
selected on the basis of the Duke algorithm described by
Pryor et al. (4). The specificity of 62% in the patients with
normal coronary angiograms is similar to that reported by
other experienced investigators (2) in this field. The conclu-
sion by Gould (2) that positron emission tomography with its
greater accuracy will prevent unnecessary catheterization
procedures due to false positive results is not entirely valid
even if cost consideration is not an issue. Similarly, the
conclusion by Diamond (1) that clinicians should view as
suspect any sensitivity and specificity derived for reports
that do not include the frequency and number of positive test
responses in the larger group of nonangiographic responses
appears to deserve a few additional comments.
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Positive versus false positive diagnoses of myocardial ische-
mia. There is as yet no diagnostic test that is 100% sensitive
and 100% specific for detecting myocardial ischemia-not
even coronary angiography! Myocardial ischemia may occur
in patients with normal coronary angiograms (or those with
insignificant stenosis) and, alternatively, ischemia may not
be evoked in patients with apparently significant stenosis by
coronary angiography. Functional measurements have re-
peatedly shown the limitations of anatomic descriptors of
coronary stenosis. For that reason. positive thallium results
in the absence of coronary stenosis may not always be false
positive (5). Further, in a given patient. knowledge that a
specificity is 80% and not 60% has a limited usefulness. An
analogy can be made, for example. with surgical mortality
results. Whereas a 2% mortality rate in a group of 100 patients
undergoing surgery is low and acceptable, for the 2 patients
who died. the mortality rate is looo/o-too high and unaccept-
able! Also. with experience we have learned to recognize
causes of false positive results such as motion. artifact, creep
and attenuation artifact. Finally, the newer imaging agents such
as technetium-99m-labeled methoxyisobutyl isonitrile (MIEI)
or technetium-99m teboroxime may pose less attentuation
artifact and, hence. decrease the rate of false positive results.
Positron emission tomography versus SPECT. The study
by Tamaki et al. (6) failed to reveal any advantage of
positron emission tomography over SPECT thallium imaging
in diagnosing coronary artery disease or in identifying indi-
vidual diseased vessels. Several recent preliminary reports
have also shown substantial false positive rates with positron
emission tomography. For example, Go et al. (7) reported a
specificity of 84% with rubidium-82 and 77% with SPECT
thallium-201 imaging. The only real advantage of positron
emission tomography appears to be in assessing myocardial
viability. The use of the reinjection technique with thallium-
201 and the use of newer imaging agents may decrease, but
will not eliminate, the need for positron emission tomogra-
phy in assessment of myocardial viability.
Advantages of SPECT imaging. The sensitivity of SPECT
thallium imaging in our experience and that of others (8) has
been uniformly better than that of planar imaging. As shown
in our report (3), false negative results were often seen in
patients with one vessel disease, mild disease or inadequate
stress. We and others have shown that the prognosis of
patients with normal exercise thallium images is benign, and
hence, the prognostic information of thallium imaging in
these patients is of great help in patient management. In our
opinion (9), patients with normal exercise thallium images do
not require revascularization procedures.
A clear advantage of SPECT imaging is in the determina-
tion of the extent of ischemia and the size of the jeopardized
myocardium. Such information is extremely useful in patient
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prognosis and is not readily available by clinical evaluation
or by treadmill exercise testing alone. Assessment of the
presence and extent of ischemia may be especially important
in patients with previous myocardial infarction.
A major shift in our utilization of nuclear imaging tech-
niques in patients with ischemic heart disease has been the
assessment of the functional consequences of coronary
artery disease. Considerable variability in the size and extent
of perfusion abnormality exists in relation to the anatomic
severity of coronary disease (10). It is possible now to quanti-
tate these data using polar maps, an approach that may even be
more suitable with the newer technetium imaging agents.
Conclusions. Regrettably. the traditional method of re-
porting nuclear imaging data as sensitivity and specificity do
not take into consideration the variability in the severity and
the extent of the perfusion abnormality. These quantitative
data are difficult to present in the framework of Bayes'
theorem, which defines a test result as either normal or
abnormal. The challenge for the future is to incorporate the
functional data as a continuous distribution in computer
programs. Such a model based on radionuclide angiographic
test results has been shown (11) to increase the diagnostic
and prognostic information for individual patients with
symptoms suggestive of coronary artery disease.
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